Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00474175 · ClinicalTrials.gov registry record · Phase 4
Benzocaine Gel Toothache Dose-Response Study
A Phase 4 study, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- Completed
- Registry status
- Phase 4
- Development phase
- 577
- Enrollment target
NCT00474175 is a Phase 4 study that has completed, run by Wyeth is now a wholly owned subsidiary of Pfizer. The registered enrollment target is 577 participants.
The verdict
NCT00474175, a Phase 4 study, has completed, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 577 participants
- Enrollment target
Study Summary
To evaluate the efficacy and safety of benzocaine gel products for the relief of toothache and to assess the subject's compliance with proposed label directions.
Interventions
- DRUG Placebo gel
- DRUG benzocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 577 participants |
| Start Date | 2007-05 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00474175
The ClinicalTrials.gov registry entry for NCT00474175 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 577 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo gel is the first listed.
NCT00474175 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00474175 about?
NCT00474175 is a clinical study titled "Benzocaine Gel Toothache Dose-Response Study". To evaluate the efficacy and safety of benzocaine gel products for the relief of toothache and to assess the subject's compliance with proposed label directions.
What is the current status of trial NCT00474175?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 577 participants. The study started on 2007-05. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00474175?
The interventions under investigation include: Placebo gel (DRUG), benzocaine (DRUG).
Who is sponsoring clinical trial NCT00474175?
This trial is sponsored by Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.